Transcript Highlights:

• And if I hear you as far as bolstering, our drug checking could improve them.
• And now any additional comments, feedback, before we go into people who use drugs and...
• Any additional comments, feedback before we go into people who use drugs and people in recovery?
• I just had a question about the role of the Attorney General in this kind of emerging drug issue.
• Any other comments before we move to the drug?

Summary: The special commission on xylazine held its fifth and final public meeting to review and finalize its report before submission to the House and Senate clerks. Chair Mindy Domb opened the meeting, noted Senator John Velis was absent due to National Guard deployment, and the commission approved the minutes from the February 9 meeting. Staff then walked commissioners through the final draft, focusing on edits since the prior review and on appendices that would be completed after the meeting. Commissioners discussed several substantive wording changes, including clarifying that xylazine is an active adulterant rather than a bulking agent, replacing “non-clinician” with “non-clinical staff,” removing or softening references to “hotspots,” and refining language about medical consequences and financial costs of delayed wound care. They also discussed adding or strengthening references to harm reduction measures, drug checking, overdose prevention centers, oxygenation, airway positioning, naloxone use, and language access considerations in educational materials. The report’s main findings and recommendations centered on best practices for oversight and enforcement, outreach and treatment, emergency response, and education/training for first responders, medical providers, non-clinical staff, people who use drugs, and people in recovery. Commissioners emphasized the need for timely, accessible, and tailored training; better data collection and public health surveillance; stronger legal protections for drug checking; and coordination among public health, public safety, and legal stakeholders to address xylazine and emerging adulterants. There was also discussion of a recommendation for the Attorney General to compile guidance for law enforcement in consultation with experts, though staff clarified that this would not be the sole function of the broader public body envisioned in the report. After reviewing the final language, the commission voted unanimously among members present to approve the final report, with one abstention on the earlier minutes vote and absent members to submit written votes within 24 hours for inclusion in Appendix A. Chair Domb then read a letter from Senator Velis expressing support for the report and its recommendations despite his inability to vote in person. Commissioners offered closing remarks thanking staff and one another for the collaborative work, and the meeting adjourned at 11:11 a.m., with staff to submit the report to the clerks and post it online.

Transcript Highlights:

• to some drug use, whether they were addicted or whether somebody gave them something.
• I'd like to provide you an update on the budget and schedule.
• And schedule.
• When it comes to our policy bills, we're running ahead of schedule.
• And now, back to our regularly scheduled programming. Please read the next bill.

Summary: The Senate opened with prayer, the Pledge of Allegiance, and several recognitions, including guests from Miami Northwestern Senior High School, Clay County, and a moment of silence for Pope Francis. Members then moved to the special order calendar after adopting a motion to reconsider the earlier failed vote on CS/SB 1080, which was temporarily postponed. The chamber also temporarily postponed several bills during the day, including measures on social media use by minors, veterans’ nursing homes, Parkinson’s disease, mental health and substance use disorders, education, educator preparation, benefits for certain officers injured in the line of duty, Brownfields, and school social workers. The Senate passed a series of bills with little or no opposition, often substituting House companions for Senate bills. These included expedited DNA testing grants for law enforcement; additional aggravating factors in capital felony sentencing; fertility preservation coverage for cancer patients; commuter rail indemnification; disposition of migrant vessels; specialty license plates; an Alzheimer’s and dementia awareness campaign; relocation of the Council on the Social Status of Black Men and Boys to Florida Memorial University; charter school changes; registration rules for sexual predators and offenders; assault and battery penalties for utility workers; juvenile justice revisions; reporting of student mental health outcomes; foster home licensure transfers; water access facilities and boating-related funding; Florida Virtual School changes; school readiness program improvements; protections against lewd sexual images of children; age-related criminal offense provisions; tampering with electronic monitoring devices; certified recovery residences; and codification of the FSU Election Law Center. Most of these bills passed overwhelmingly, though the charter school bill and the aggravating factors bill drew more divided votes. One of the most debated measures was SB 820, codifying the Office of Faith and Community. Senator Polsky offered an amendment to bar political activity by office employees while on duty and using government resources, citing alleged election-related emails and concerns about mixing government and religious influence. Supporters argued the amendment was needed as a guardrail; opponents said existing law already covered the conduct and that the amendment could be confusing or overly broad. The amendment failed 13-23, and the underlying bill passed 27-9 after extended debate about faith, politics, and the office’s role. Another notable debate involved SB 954 on certified recovery residences, where senators emphasized the need for stable housing in addiction recovery and the bill passed unanimously after supportive remarks from members who had personal experience with recovery. The Senate also passed SB 674 on bonuses for county tax collector and property appraiser employees after questions about safeguards and the purpose of the bonuses.

Transcript Highlights:

• that is a lot of the bigger cities, if you want to call them bigger, in West Virginia, have a lot of drug
• And so it's actually Marion County; they automatically schedule them.
• And so it's actually in Marion County, they automatically schedule them out when I get appointed a case
• Magistrates aren't giving guys from out of state from Detroit with drug charges PR bonds.
• It could be drug testing.

Committee: Senate Judiciary

Keywords: 994, senate, all

Transcript Highlights:

• Back to our regularly scheduled hearings.
• These miracle drugs, however, are very expensive.
• We are not asking you to lower our drug prices.
• And it's especially true for cancer patients because many of the drugs they're on are newer drugs that
• You will get your drug for 12 straight months.

Committee: House Health and Mental Health

Summary: The committee first heard House Bills 2365, 2490, and 2249, a bipartisan version of Elijah’s Law, which would require child care facilities to receive training and guidance on recognizing and responding to food allergies and anaphylaxis. Sponsors described the bill as a response to the death of Elijah, whose daycare did not administer epinephrine quickly enough after a food exposure. Witnesses in support, including a parent and food allergy advocate, said the measure would improve preparedness and save lives. Committee members asked about whether the bill should use broader epinephrine terminology, whether the requirements could also be handled through child care licensing rules, and whether the bill was already included in a larger measure. No opposition was presented, and the hearing on those bills was closed. The committee then heard House Bill 1965, which would require insurers to reimburse athletic trainers for covered services and add athletic trainers to the practitioner definition for billing purposes. The sponsor and athletic training witnesses said the bill would recognize athletic trainers as licensed health care providers, improve access in rural and underserved areas, and allow reimbursement when trainers work in clinics, hospitals, or other non-school settings. Committee members raised repeated questions about the difference between athletic trainers and physical therapists, whether school-based services were already paid through contracts, whether the bill would increase costs or create double payment, and how diagnosis and billing would work under the current scope of practice. Opponents from Blue Cross and Blue Shield of Kansas City and the Missouri Insurance Coalition argued the bill would create a mandate, increase costs, and expand billing before clarifying the underlying scope of practice. No vote was taken in public hearing. The committee then moved into executive session and voted several bills do pass. A substitute was adopted for House Bill 1826 and the committee substitute for House Bills 1826, 2560, 2349, and 2194 passed 17-0. House Bill 1783 also passed 17-0. House Bill 2372, which incorporated multiple related provisions including changes to epinephrine terminology and other committee items, passed 17-1 after a substitute and amendment were adopted. House Bill 1827, the occupational therapy bill related to disabled placards and license plates, passed 18-0. The committee then returned to public hearing and heard House Bills 1941 and 2279, which would prohibit copay accumulator programs for fully insured plans so that third-party assistance counts toward a patient’s deductible and out-of-pocket maximum. Sponsors and a rheumatologist testified that the bills would prevent patients with serious illnesses from being forced to pay the same deductible twice and said similar laws have been enacted in many other states. Opponents from America’s Health Insurance Plans argued the measure would affect only a minority of plans, raise costs in the individual and small-group market, and could worsen affordability for remaining enrollees. The hearing ended without a vote on those bills.

Transcript Highlights:

• they end up coming to me, but at that point, they have a criminal record, some of them, they have a drug
• I'm going to start drinking, I'm going to start doing drugs.
• Well, while not much can certainly mean something to an individual, bringing the fee schedule into parity
• committee chair that the subcommittee has completed its deliberations and recommends that SB 651 be scheduled
• that the subcommittee has complete, has completed its deliberations and recommends that SB 1931 be scheduled

Committee: House S/C on Defense & Veterans' Affairs

Transcript Highlights:

• They end up coming to me, but at that point, they have a criminal record; some of them have a drug problem
• I'm going to start drinking, I'm going to start doing drugs, I'm going to start doing illicit stuff.
• It brings the fee schedule into parity with other military plates and also clarifies and updates statutory
• committee chair that the subcommittee has completed its deliberations. and recommends that SB 651 be scheduled
• committee chair that the subcommittee has completed its deliberations and recommends that SB 1227 be scheduled

Bills: HB4458 , SB651 , SB1227 , SB1931

Committee: House S/C on Defense & Veterans' Affairs

Keywords: veterans, service members, military transition, Texas Veterans Commission, pilot program, self-reliance, employment assistance, housing assistance, mental health services, career training, veterans service organizations, spouses and dependents, military families, Texas military forces, post-separation support, reentry services, workforce development, benefits navigation, transition assistance, SB 651

Transcript Highlights:

• If they have special needs, they need drug treatment.
• Each facility scheduled their own; we centralized that.
• money through the drug transactions.
• Any further questions of Oklahoma Bureau of Narcotics and Danish Drugs?
• Seeing none, Director, thank you. of narcotics and danish drugs.

Summary: The Appropriations Subcommittee on Public Safety and Judiciary heard presentations from several agencies. The Office of the Chief Medical Examiner reported full National Association of Medical Examiners accreditation, major improvements in turnaround times, staffing growth to 18 forensic pathologists, and expanded rural coverage, but warned that a flat budget would leave it short of funds by August. The agency requested $4.5 million in recurring funding for professional staff and operations, citing rising supply, transport, IT, and facility costs, and said failure to fund the request would cause a catastrophic collapse. Members asked about cremation fees, other revenue sources, and the consequences of not funding the request; the chair said the recommendation would be forwarded but not necessarily adopted. The Council on Judicial Complaints said complaints against judges have roughly doubled since 2018, with most complaints involving dissatisfaction with judicial rulings rather than misconduct. The council emphasized its goal of responding within 90 days, its new judges college to prevent ethics problems, and the cost of removal proceedings. It requested an additional $125,000 on top of its current $300,000 appropriation to cover rising operating costs, a lease increase, judicial college expenses, and salary adjustments. Senators asked about case prioritization, turnover, staffing, and whether a specific courtroom incident could be investigated; the director said it would be an appropriate complaint to review. The Oklahoma Indigent Defense System described heavy caseloads in rural counties, a mix of satellite offices and county contracts, and a need to reduce attorney workloads, especially in Norman and Lawton. It requested funding for six resource navigators, a project manager, direct-care support, eight additional attorneys, internal training, and continued county contract funding, while also discussing possible diversion programs and grant opportunities. The Department of Corrections requested increases for county jail backup per diem and ICON maintenance, highlighted contraband interdiction, centralized visitation, mobile check-ins, and tablet-based efficiencies, and discussed an ICE detention contract at Watonga that brings in monthly revenue and jobs but is not counted in the budget request. The Oklahoma Bureau of Narcotics and Dangerous Drugs presented a revised legacy-fund request tied to purchasing and remodeling a building shared with OSBI, saying the new plan would cost about $25 million total and save money compared with new construction; it also noted declining wire-transfer revenue tied to fewer grow operations and other enforcement changes.

Transcript Highlights:

• That's what we mean by drug-resistant epilepsy.
• Not even all drugs.
• It's not like every drug; you have to say these 10 drugs are what I'm testing for.
• So, drugs—the word "drugs" is a consistent language in the DWI bill.
• Under state law, it is recognized as a legal drug.

Committee: House House Health & Human Services

Transcript Highlights:

• Doctors are scared to write recommendations for this because marijuana is a Schedule I drug, and until
• Doctors are scared to write recommendations for this because marijuana is a Schedule I drug, and until
• It's still a Category 1, Schedule 1 drug.
• These drugs can't pause anything.
• These drugs are harmful. There is more and more research proving... These drugs are harmful.

Bills: LB815A , LB838A , LB912A , LB972A , LB1126A , LB962A , LB1114 , LB921 , LB937 , LB803 , LB803A , LB1032 , LB1032A , LB1075 , LB1075A , LB889 , LB878 , LB933 , LB304 , LB304A , LB1096 , LB1096A , LB1165 , LB1165A , LB958 , LB958A , LB762 , LB1187 , LB966 , LB929 , LB962 , LB753 , LB788 , LB913 , LB1055 , LB1195 , LB429 , LB721 , LB722 , LB727 , LB743 , LB745 , LB749 , LB778 , LB787

Keywords: LB815A, LB815, appropriation, appropriations bill, Nebraska Department of Revenue, Motor Fuel Tax Enforcement and Collection Cash Fund, motor fuel tax, gas tax, fuel tax, tax enforcement, tax collection, cash fund, budget, state spending, per diem, salaries, fiscal year, enrollment and review, final reading, Nebraska

Transcript Highlights:

• /c><00:26:05.840><c> 15</c> people inappropriately scheduled for 15 people inappropriately scheduled
• ><c> increases</c><01:08:43.759><c> in</c> drugs.
• We're seeing increases in drugs.
• Over food, drugs, or or a place to stay?
• A groundbreaking 2014 study or drugs.

Bills: HF2779 , HF1645 , HF1885 , HF1289 , HF1534 , HF2707 , HF1675 , HF3046

Committee: House Health Finance and Policy

Keywords: health care transparency, ownership disclosure, control reporting, health care consolidation, private equity, management services organization, MSO, provider organization, health insurer, pharmacy benefit manager, hospital system, affiliate reporting, financial disclosure, public reporting, market concentration, horizontal consolidation, vertical consolidation, health care ownership, corporate practice, health care regulation

Transcript Highlights:

• Yeah, and I think one of the issues with some drug checking equipment is that it doesn't tell you how
• I think Brandeis—we can look; Brandeis does materials related to their drug checking activities, does
• And I hear you as far as bolstering our drug checking could improve them.
• Any additional comments, feedback before we go into people who use drugs and people in recovery?
• I just had a question about the role of the Attorney General in this kind of emerging drug issue.

Keywords: 995, all

Summary: The Special Commission on the Public Health Effects of Xylazine held its fifth and final public meeting to review and approve the final draft of its report before submission to the House and Senate clerks. Chair Mindy Domb opened the meeting, noted Senator John Keenan’s absence due to National Guard deployment, approved the prior meeting minutes, and explained the process for incorporating final edits and late votes into appendices. Commissioners then voted to allow staff to make agreed-upon language changes after the meeting, and later voted on the final report itself. Staff walked commissioners through the report’s redlines and substantive updates. Changes included clarifying that xylazine is an active adulterant rather than simply a bulking agent, replacing “non-clinician” with “non-clinical staff,” removing or revising references to “hotspots” in favor of more accurate language about local trends, and refining language on wound care to refer to medical consequences and financial costs. The report also added or strengthened discussion of harm reduction measures such as drug checking, mobile health services, overdose prevention centers, oxygenation and airway support during overdose response, and the importance of naloxone remaining available while recognizing its limits for xylazine exposure. Commissioners also discussed data collection, legal protections for drug checking, and the role of the Attorney General in guidance and coordination on emerging drug threats. The commission then took a final vote, with the members present voting to approve the report. A letter from Senator Velis, who was also absent due to active duty orders, was read into the record expressing support for the report and its recommendations. In closing comments, commissioners and staff thanked one another for the collaborative work and described the report as a useful public health resource. Chair Domb adjourned the meeting at 11:11 a.m., noting that the final report would be submitted and posted online for public access.

Transcript Highlights:

• access to diagnostics and treatment, sub-bulleted by AD, which is an acronym for Alzheimer's Disease, Drugs
• We now feel that with two FDA-approved drugs and most recently an FDA-approved blood test, we know that
• But quality of life is something that is expressed in terms of flexible work schedule, job opportunities
• If only baby deliveries could be scheduled, we could have a baby mobile, like the bookmobile.
• Right now, we don't have a schedule that really works with the high school.

Committee: House Legislative Health & Human Services Committee

Transcript Highlights:

• we were with Blue Cross Blue Shield and rebates really started becoming popular on the prescription drug
• out-of-pocket maximums, as well as some formulary maximums, if the participant is willing to use the drugs
• ... ...as well as some formulary maximums if the participant is willing to use the drugs that are on
• Well, committee, we're actually ahead of schedule now.
• We are well ahead of schedule.

Summary: The Employee Benefits Committee met to approve prior minutes, hear presentations on state employee health insurance, compensation, leave, and related policy issues, and then recess for lunch. PERS reviewed the history and structure of the state health plan, noting the long-standing state-paid family coverage, cost-control measures, wellness incentives, the current grandfathered PPO and high-deductible options, and the effects of recent benefit mandates such as insulin caps, prosthetic coverage, medication management, prescription copay changes, and ambulance balance-billing limits. Committee members questioned the fiscal impact of adding benefits and the possible cost of moving to a non-grandfathered plan, while PERS and HRMS emphasized that health insurance remains the top-ranked employee benefit and that any major plan changes should be considered carefully. HRMS also presented compensation comparisons showing state pay generally below private-market benchmarks, discussed targeted market equity adjustments, identified ongoing recruitment and retention concerns in fields like nursing, IT, engineering, and attorneys, and reviewed leave policies, tuition reimbursement, and family leave comparisons with neighboring states. Job Service provided labor market data showing low unemployment, high labor force participation, and wage growth that still trails some neighboring markets, and OMB explained that prevailing wage requirements apply to federally funded projects under Davis-Bacon, not to ordinary state contracts. After lunch, the committee took up the required process for health insurance mandate bills and adopted an amendment to Joint Rule 211. The amendment clarified that the deadline for submitting mandate measures is intended to allow time for all required reports, including both the cost-benefit analysis and any Employee Benefits Committee actuarial report, while leaving the existing deadline unchanged. The amendment was adopted on a roll call vote, with several members voting yes and a few no votes recorded. The committee then moved into its jurisdiction review of bill drafts, beginning with a bill that would automatically renew pre-tax dental and vision elections; members debated whether it had any actuarial or administrative impact on PERS or the state, and the chair explained that the committee’s role was only to decide whether further analysis was needed before later testimony and recommendations.

Transcript Highlights:

• 340B drug pricing program.
• 340B drug pricing program.
• </c> safety net providers access to 340b drug safety net providers access to 340b drug discounts<00:18
• </c><00:25:41.159><c> manufacturers</c> the part of the uh drug manufacturers the part of the uh drug
• I'm with the State Department of Health, Food and Drug Branch.

Committee: House Judiciary & Hawaiian Affairs

Keywords: 910, house, all

Summary: The committee first heard House Bill 302, which would repeal the requirement that a provider-patient relationship for medical cannabis certification be established in person first. The Department of Health said it supported the House Draft 2 version as a way to expand patient access, and several testifiers from the medical cannabis community and dispensary industry supported the bill, especially for patients on outer islands or those unable to travel. One witness asked that earlier language removed in committee be restored to further improve access. Representative Shimizu asked whether follow-up in-person visits would still occur, and DOH responded that this varies by provider, with some continuing in-person care and others moving to telehealth for chronic conditions. The committee then took up House Bill 712, relating to the federal 340B drug pricing program and contract pharmacies. The Office of Consumer Protection and the Attorney General’s office both said they supported the bill’s purpose but wanted it clarified and possibly moved into a standalone chapter rather than chapter 481B. Supporters, including Hawaii Pacific Health and the Queen’s Health Systems, said the bill is needed to protect safety-net funding and access to discounted drugs, citing large financial benefits from 340B and losses caused by manufacturer restrictions on contract pharmacies. PhRMA opposed the bill, arguing the issue is not access to discounts but accountability and transparency in how contract pharmacies distribute benefits, and said it was willing to discuss amendments. Members asked follow-up questions about whether there was data showing misuse; PhRMA said it did not have numbers, while hospital witnesses said the program is federally audited and used appropriately in Hawaii. Finally, the committee heard House Bill 1482, HD1, which would tighten hemp and controlled-substance definitions to exclude Schedule I cannabinoids from manufactured hemp products and clarify the treatment of artificially derived cannabis. The Department of Health supported the measure, saying it adds clarity to existing prohibitions. Kūre Hawaii and other supporters said it would close loopholes involving Delta-8 and similar products. An individual testifier urged stronger language to also cover compounds such as HHC, THCA, THCP, and THCO. In response to questions about enforcement against mislabeled hemp products, DOH explained that THC percentages are relative to product weight, that some products can remain under the hemp threshold while still containing significant THC, and that hemp flower is already prohibited from direct retail sale, though enforcement can be complicated and involves both administrative and criminal authorities.

Transcript Highlights:

• The fourth reform modernizes the Medicaid-prescribed drug services program.
• And all this bill does is repeal the sunset clause scheduled for June 30, 2026.
• But we also started that battle to really address the drug issue in the state of Florida.
• addict, prostitute, and drug dealer be on the school board?
• A man's current law relating to drug paraphernalia to exclude from the definition of illegal drug paraphernalia

Summary: The Senate convened with a quorum, opening prayer, Pledge of Allegiance, and doctor-of-the-day introduction, then moved through a long special-order calendar. Early proceedings included a resolution honoring former Governor and U.S. Senator Bob Graham and a moment of silence for firefighter Roger Timmy Miley. The chamber also heard several member introductions and recognitions before taking up bills. The most substantial debate centered on CS/CS/SB 1758 on public assistance and Medicaid/SNAP reforms. The bill would strengthen fraud enforcement, impose a Medicaid work requirement for able-bodied adults, expand behavioral health services through a waiver, modernize Medicaid pharmacy purchasing, and require a SNAP fraud-reduction plan and photo ID on EBT cards. Senators Berman, Smith, Bracy Davis, Osgood, and others argued for Medicaid expansion and added protections for vulnerable SNAP recipients, while Gates defended the bill as a compliance and cost-saving measure. Multiple amendments were offered, including Berman’s Medicaid-expansion condition and Osgood’s SNAP photo-ID safeguards; both were defeated. The bill was placed on the calendar for third reading after extended questioning. The Senate then passed a series of bills, often substituting House companions before final vote. These included tax conformity legislation (7031/7048), technology and computer science education (1503/1694), Parkinson’s disease registry and related public-records measures (1443/1684), designation of the SS American Victory as the official state flagship (249/1656), electronic payments for local governments (967/1612), legal tender and related public-records exemptions for gold, silver, stablecoins, and virtual currency kiosks (1311/1588/1087/7044/1568), local government finance and spending transparency (1329/1566), digital voyeurism (1536), insurance customer representative licensing (1343/1504), and medical freedom legislation (1756) with amendments on anti-kickback rules and vaccine information materials. Most bills passed on largely party-line or near-unanimous votes, with several amendments adopted and some withdrawn; the medical freedom bill was still under consideration at the end of the excerpt.

Transcript Highlights:

• So the rate schedule was changed last year.
• So the rate schedule was changed last year. Thank you.
• So the rate schedule was changed last year, so generally speaking, those rates went up.
• By way of background, the Anti-Drug Abuse Act of 1988 established the high-intensity drug trafficking
• area program to provide grant funding to coordinate operations related to drug trafficking.

Summary: The Ways and Means Committee met on February 6, 2026, and first voted to suspend the five-day notice rule for all bills on the agenda. Senators Braun and Gildon objected, arguing the bill needed more public review and that the fiscal note had only just been released, but a roll call vote passed 15-9 and the committee proceeded to Senate Bill 6346. Staff briefed SB 6346 as a proposal to create a 9.9% income tax on Washington taxable income above a $1 million per-household standard deduction, with a $50,000 charitable deduction, apportionment rules for nonresidents and certain professions, quarterly estimated payments, and credits for capital gains tax and certain business taxes. Staff said the tax would begin in 2029 and eventually raise about $3.5 billion annually from roughly 30,000 taxpayers. The bill also would expand the Working Families Tax Credit, create a sales tax exemption for grooming and hygiene products, increase the small business B&O tax credit and filing threshold, and end the B&O surcharge on high-grossing businesses one year early. Members questioned the bill’s constitutionality, its exemption from referendum, treatment of student athletes, natural-resource industries, and whether real estate gains would be captured. Public testimony was sharply divided. Supporters, including labor groups, educators, health care advocates, counties, child care workers, and some business owners and high-income individuals, said the bill would make the tax code more progressive and provide stable funding for health care, education, child care, public defense, and other services, while expanding the Working Families Tax Credit. Opponents, including many small business, construction, housing, and taxpayer advocates, argued the measure would function as a tax on pass-through businesses and retained earnings, harm housing production and investment, encourage wealthy residents and businesses to leave the state, and violate the state constitution or the will of voters. No final action on SB 6346 was taken during the hearing.

Transcript Highlights:

• the process to create the drug.
• and maps the process to create the drug.
• into the drugs are actually made overseas.
• I don’t know that all of the drugs that they’re pursuing are already FDA approved.
• Not so much about that, but have we scheduled public testimony for Division of Social Services?

Summary: The House Budget Committee heard the Department of Economic Development’s fiscal year 2027 budget presentation, beginning with Director Michelle Hadaway and division leaders. The department emphasized that most of its budget is federally funded and walked through requests for regional engagement, international trade and investment offices, business recruitment and marketing, Delta Regional Authority dues, business and community solutions, tax increment financing, MODESA, DRPP, CDBG, disaster recovery, Missouri Main Street, AmeriCorps, Missouri One Start, the Missouri Technology Corporation, semiconductor and API reshoring efforts, SSBCI, and other economic development items. Members repeatedly asked about lapses, one-time appropriations, whether general revenue could be reduced or replaced with other funds, and how the department prioritizes federal and other non-GR sources. Several members also praised regional engagement, Missouri Partnership, and rural economic development efforts. A major portion of the discussion focused on specific one-time or performance-based projects. Members questioned the large GR transfer for TIFs and MODESA, the use of funds for the Urban League plaza renovation, the Northeast Missouri housing fund, the Highway MM corridor, and the Missouri Technology Corporation. Department witnesses explained that many of these amounts are based on projected performance or are tied to multi-year obligations, and that some unspent balances reflect project timing, federal reimbursement timing, or delayed construction. The committee also discussed the Missouri Main Street program, with staff explaining it supports both new and existing Main Street communities and can be adapted for county-wide models. The committee spent significant time on workforce and innovation programs. Missouri One Start described its customized training and upskilling programs, including a statutory fund switch to align with existing law, while members asked for more data on participation and impact. Missouri Technology Corporation explained that reduced funding last year limited some entrepreneur-support programs, and that its venture fund has leveraged state dollars into private capital and jobs. Members also discussed the API reshoring item and semiconductor funding, asking what the money would do, what companies would benefit, and how much federal leverage the state could expect. Witnesses said the API request supports a nonprofit center working with existing Missouri companies to reshore pharmaceutical production, while the semiconductor item is tied to federal matching opportunities that have moved slowly. The committee did not take final action on the budget during the portion of the hearing provided. The chair recessed the committee to go to session, stating that the hearing would resume afterward and that public testimony on House Bill 2007 would follow completion of the department presentation.

Transcript Highlights:

• With respect to the impacts of SB 1323 and Prop. 36, Prop. 36 provides for specified drug and retail
• And we typically, depending on schedule, are able to schedule it sequentially each year.
• Medi-Cal and Drug Medi-Cal Organized Delivery System services.
• You'll hear me say DMC-ODS for Drug Medi-Cal Organized Delivery System repeatedly here.
• My name is Sarah Weber with the Drug Policy Alliance.

Summary: The subcommittee heard presentations from the Department of State Hospitals (DSH), the Commission for Behavioral Health, and the Department of Health Care Services (DHCS) on budget proposals and implementation updates. DSH outlined its proposed 2026-27 budget, including funding for patient operating expenses, IST solutions savings, conditional release program costs, LPS bed allocation changes, electrical infrastructure projects at Napa and Patton, SB 380 transitional housing feasibility work, and expanded dental services at Metropolitan and Patton. DSH also reported that it has met court-ordered IST treatment benchmarks in the Stiavedi v. Clinton case, with average time to initiate treatment down to about five days and pending placements reduced to roughly 250, while noting that Proposition 36 could increase referrals and SB 1323 may divert some individuals earlier into community-based treatment. Members asked about rising outside hospitalization costs, Medicare enrollment, the timing and structure of capital projects, and whether IST solution funds are being fully used; DSH said the savings reflect slower-than-expected ramp-up of community programs and that the Central California FACT replacement program is still on track for January 2027 activation. The Commission for Behavioral Health described its role under the Behavioral Health Services Act (BHSA), including data, evaluation, grantmaking, technical assistance, and transparency work. It highlighted the new statewide Innovation Partnership Fund, a five-year, $20 million-per-year program with small and large grant categories; the first RFA drew strong interest, with more than 400 questions and over 1,000 bidders’ conference participants. The Commission also discussed a proposed extension to spend down about $4.1 million remaining for the Alcove Youth Drop-in Center grants so sites can finish implementation and Stanford can complete the final evaluation. Members asked about grant duration, whether projects can be renewed, what qualifies as innovation, and whether the fund could support service delivery rather than awareness campaigns or training; the Commission said awards are expected to be three-year contracts and that proposals must be new or meaningfully expanded approaches that support BHSA priority populations. DHCS reviewed major behavioral health changes under CalAIM and BH Connect, including peer support, mobile crisis, contingency management, traditional health care practices for tribal members, updated specialty mental health access criteria, and new substance use treatment standards based on ASAM’s fourth edition. DHCS reported strong contingency management results, with more than 13,000 members served and 95% testing negative for stimulant use during treatment, and said 21 Indian health care providers have been approved to offer traditional health care practices. It also described BH Connect initiatives such as the $1.9 billion access reform and outcomes incentive program, workforce investments, evidence-based practice expansion, IMD participation by four counties, and transitional rent services. On BHSA implementation, DHCS said it is not tracking individual county contract cuts but is monitoring county plans and statewide outcomes, while stakeholders raised concerns about local prevention and service gaps. DHCS also outlined its H.R. 1 implementation strategy, including outreach, streamlined renewals, exemptions for disabled, substance use, and medically frail individuals, and proposed clinic navigator and outreach funding; it said it has not yet produced a focused estimate of H.R. 1 impacts on behavioral health populations. The discussion ended with DHCS noting that B-CHIP bond funding has supported 437 infrastructure projects, creating 546 new or expanded facilities and more than 9,500 residential beds across the state.

Transcript Highlights:

• This is about whether a mother fills her child's inhaler prescription, whether seniors schedule a follow-up
• I wish we had the ability to set the spending targets on pharmaceutical drugs.
• , the schedule that’s endorsed by the AAP, the American Academy of Pediatrics.
• They're the things like hospital operating costs, prescription drug prices, and doctors' fees.
• Drug prices and doctors' fees.

Summary: The joint informational hearing of the Senate and Assembly Health Committees focused on the “cost of uncertainty” in health coverage, access, and affordability amid federal policy changes. Opening remarks from committee leaders and members emphasized that California’s gains under the Affordable Care Act and Health for All policies—high coverage rates, consumer protections, and lower uninsured rates—are now threatened by federal rollbacks, including the expiration of enhanced premium tax credits and H.R. 1. Members repeatedly cited rising premiums, skipped care, medical debt, and the risk of coverage losses, especially for low-income Californians, workers, seniors, and immigrant communities. The first panel featured federal policy and state implementation experts, including Don Joyce, Jessica Altman of Covered California, and Elizabeth Lansberg of HCAI’s Office of Health Care Affordability. Testimony described the ACA’s coverage expansions and the current federal threats: shorter open enrollment, more verification requirements, loss of enhanced subsidies, and changes affecting immigrants and preventive coverage. Covered California reported that average monthly premiums could nearly double without the subsidies, new enrollment is down sharply, and more consumers are shifting into bronze plans with higher deductibles. HCAI explained its affordability strategy through spending targets, consolidation review, and primary care investment, while members asked about the impact of federal cuts on provider taxes, uncompensated care, and whether California can sustain coverage without new revenue. The second panel, with UC Berkeley Labor Center’s Miranda Dietz and California Health Care Foundation’s Christoph Stremikis, broadened the discussion to statewide cost drivers and consumer impacts. They highlighted that more than half of Californians under 65 rely on job-based coverage, yet premiums, deductibles, and out-of-pocket costs have risen faster than wages. They also pointed to medical debt, administrative waste, market consolidation, and underinvestment in primary care as major drivers of unaffordability. Members asked about the 25% of health spending that does not improve patient care, the role of fraud versus administrative friction, the effect of cost growth targets on workers, and the need for preventive care and possible revenue solutions. The hearing then moved to a third panel on human impacts, beginning with testimony from a Central Valley promotora describing how families are choosing lower-tier coverage, struggling with diabetes care, and facing higher premiums after subsidy losses.

Transcript Highlights:

• Transitional Services is continued on the next slide, as you can see here, where we schedule, monitor
• We're not making you do two drug tests or two clinicians.
• And our next hearing right now is scheduled for March 9th at 10 a.m. I mean, Sheriff Kay Lane.
• So that's our next hearing schedule.
• So that's our next hearing schedule.

Summary: The Special Commission on Criminal Justice Reform 3.0 heard a presentation from the Massachusetts Parole Board focused on how parole, probation, the Department of Correction, sheriffs, and community providers coordinate reentry and supervision. Chair Angela Gomez described the board’s mission, its discretionary parole process, and the work of its transitional services, life sentence, victim services, and field services divisions. She highlighted 2024 activity including 2,810 institutional release hearings, 141 life-sentence hearings, 100 victim access release hearings, 18,238 victim notifications, 53 pardon petitions, 70 commutation petitions, 41 early termination applications, and supervision of about 2,993 committed parolees. She also emphasized the board’s shift toward evidence-based practices, individualized conditions, graduated sanctions, and more service-oriented supervision, including GPS guidelines and community-based interventions. Members focused heavily on data questions and the practical overlap among agencies. Senator Brownsberger and others asked for clearer breakdowns of releases, active supervision, average length of supervision, and distinctions between parole, mandatory release, revocations, and interstate compact cases. The board explained that some figures combine in-state and out-of-state cases, that roughly 400-plus people on supervision are lifers, and that annual revocations can remain technically supervised until final hearings. Members also asked for more detailed outcome data on employment, housing, treatment, and program retention, as well as a clearer breakdown of people who refuse parole versus those who decline after a grant. The board said it could provide follow-up data and noted that many refusals are driven by pending cases, desire to avoid supervision, or preference for serving time inside. The discussion also covered collaboration with UMass, including risk assessment research, training on best practices, and real-time support for medication and drug-testing issues through community pathways. The board and commissioners described shared housing and reentry resources such as MASH, community justice resource centers, sheriff-run programs like Rocky Hill and HOPE, and other placements that help stabilize people after release. Several speakers stressed that housing is the biggest gap and that agencies are trying to keep people in the community with employment, benefits, treatment, and safe housing. The commission also received an update on the Mattis-related clemency/parole cohort: 210 individuals were identified, 144 were immediately eligible for hearings, 100 hearings had been completed, 10 were scheduled, and some had postponed or were still being calculated for eligibility. The meeting ended with plans for a March 9 public hearing and a request for follow-up data and continued site visits before the commission moves into recommendations.